missing translation for 'onlineSavingsMsg'
Learn More

DR4 Mouse anti-Human, FITC, Clone: DR-4-02, Invitrogen™

Mouse Monoclonal Antibody

Brand:  Invitrogen A15746

Product Code. 15205834

  • € 312.00 / 0.10mg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel member in the TNF family was recently identified and designated TRAIL (for TNF-related apoptosis-inducing ligand) and Apo-2L (for Apo-2 ligand). TRAIL is a type II membrane protein and expressed in a variety of human tissues. Two novel death domain containing receptors DR4 and DR5 have been identified as the receptor for TRAIL. Like TNF and Fas ligand, TRAIL induces apoptosis and NF-βB activation in many tissues and cells.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DR4
Monoclonal
0.1 mg/mL
PBS with 0.2% BSA and 15mM sodium azide; pH 7.4
O00220
TNFRSF10A
Human CD261
100 μg
Primary
Human
Antibody
IgG1
Flow Cytometry
DR-4-02
FITC
TNFRSF10A
APO2, CD261, DR4, MGC9365, TRAILR-1, TRAILR1
Mouse
Purified
RUO
8797
4° C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.